Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1996-3-6
|
pubmed:abstractText |
The study shows that antibodies to cardiolipin which are commonly found in young postinfarction cases may present a high risk for recurrent coronary manifestations. IgG and IgM antibodies to cardiolipin (C1Ab) were determined in 50 healthy individuals and 72 patients with coronary disease: 26 with acute infarction (A) and 24 with chronic infarction (C) as well as 22 with angina pectoris (AP). Lipid status parameters as risk factors were measured in all patients: total cholesterol, LDL, HDL cholesterol, triglycerides and apolipoprotein (a). Out of 72 patients suffering from coronary disease 20 (27.7%) had elevated C1Ab IgG (12.36 +/- 3.7 GPLU/ml). Rise of C1Ab IgM was not evidenced in any of the patients. C1Ab IgG were significantly elevated (p < 0.01) in patients with chronic myocardial infarction and angina pectoris (p < 0.05) while in cases of acute myocardial infarction significant elevation of these antibodies was not evidenced.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0025-8105
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
20-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8569595-Angina Pectoris,
pubmed-meshheading:8569595-Antibodies, Anticardiolipin,
pubmed-meshheading:8569595-Coronary Disease,
pubmed-meshheading:8569595-Female,
pubmed-meshheading:8569595-Humans,
pubmed-meshheading:8569595-Immunoglobulin G,
pubmed-meshheading:8569595-Immunoglobulin M,
pubmed-meshheading:8569595-Lipids,
pubmed-meshheading:8569595-Male,
pubmed-meshheading:8569595-Middle Aged,
pubmed-meshheading:8569595-Myocardial Infarction
|
pubmed:year |
1993
|
pubmed:articleTitle |
Measuring of cardiolipin antibodies and plasma lipids in different stages of coronary disease.
|
pubmed:affiliation |
Institute of Nuclear Medicine, University Clinical Centre, Belgrade.
|
pubmed:publicationType |
Journal Article
|